Cellectis (CLLS) Misses Q3 EPS by 3c

Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.05 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Apple announced foldable iPhone Duo, starting at $1,999
• Dunkin' Boss Named Interim CEO of Inspire Brands Ahead of IPO - WSJ
• Signet Jewelers (SIG) call put ratio 1 call to 1 put with a focus on October 100 puts and January 130 calls as share price up 20.9%